Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmacoepidemiology is Scopus-indexed (Q2, CiteScore 1.9), WoS ESCI, DOAJ. Published by Multidisciplinary Digital Publishing Institute (MDPI).
Checked against the index lists dated .
ISSN 2813-0618Verify ISSN ↗
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 26 / 57 | 55th | Q2 |
| Public Health, Environmental and Occupational Health | 458 / 725 | 36th | Q3 |
| Pharmacology (medical) | 192 / 278 | 31st | Q3 |
| Genetics | 300 / 357 | 16th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q2, CiteScore 1.9.
Pharmacoepidemiology is Q2 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 26 of 57), Q3 in Public Health, Environmental and Occupational Health (rank 458 of 725) and Q3 in Pharmacology (medical) (rank 192 of 278), by CiteScore 2025. It is ranked in 4 subject areas in all.
Pharmacoepidemiology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.9, which places it in quartile Q2 at the 55th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.354, quartile Q2, with an H-index of 6.
The publisher lists an article processing charge of about US$1,207 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Pharmacoepidemiology is published by Multidisciplinary Digital Publishing Institute (MDPI). Its ISSN is 2813-0618.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Pharmacoepidemiology has an h-index of 31 and a 2-year mean of 1.67 citations per paper (OpenAlex). Its Scopus CiteScore is 1.9, quartile Q2. On 2-year citations it ranks #20 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Pharmacoepidemiology published 29 papers in 2025; its busiest recent year was 2006 with 53. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2023–2026), authors are most often from United States (26.8%), United Kingdom (6.3%) and Canada (6.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.